Intas Pharmaceuticals Limited Montelukast Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Montelukast Export Records India — #8 Exporter, 400 Shipments, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Montelukast

India Pharmaceutical Trade Intelligence

$168.3M510 Suppliers138 CountriesHS 30049099

ExportsIndia → UNITED STATES58.1%India → PHILIPPINES7.9%

ImportsUNITED STATES → India$7.2K MALTA → India$6.9K

#1 Buyer: AMERISOURCE HEALTH

Intas Pharmaceuticals Limited — Montelukast Exporter #8 | $3.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Montelukast Exporter Profile

Indian Pharmaceutical Exporter · #8 for Montelukast · $3.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #8 Indian exporter of Montelukast with $3.8M in export value and 400 verified shipments. Intas Pharmaceuticals Limited holds a 2.2% market share in Montelukast exports across 10 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Montelukast Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Montelukast export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Montelukast?

Country	Value	Shipments	Share
AUSTRALIA	$1.3M	81	37.2%
UNITED KINGDOM	$1.1M	79	32.7%
NETHERLANDS	$798.8K	111	23.7%
CANADA	$100.2K	7	3.0%
POLAND

Who Are the Top Buyers of Montelukast from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD UK	UNITED KINGDOM	$1.1M	45
SANDOZ PTY LTD	AUSTRALIA	$444.1K	21
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$247.5K	13
SANDOZ PTY LIMITED	AUSTRALIA	$223.4K	7
APOTEX PTY LTD	AUSTRALIA	$214.2K	10
BROCACEF NL : HUB	NETHERLANDS	$213.1K	46
APOTEX PTY LIMITED	AUSTRALIA	$87.9K	2
BROCACEF NL HUB	NETHERLANDS	$74.5K	9
APOTEX PTY LTD.	AUSTRALIA	$71.9K	4
ALLOGA FRANCE	NETHERLANDS	$64.8K	21

Intas Pharmaceuticals Limited supplies Montelukast to 39 buyers globally. The largest buyer is ACCORD UK (UNITED KINGDOM), followed by SANDOZ PTY LTD (AUSTRALIA) and BROCACEF NL HUB BROCACEF HEALTHCAR (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Montelukast Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X1	$372.2K	13
PHARM.DRUGS&MEDICINE.MONTELUKAST SANDOZ	$286.7K	12
PHARMA DRUGS & MEDI Montelukast Accord 10 mg AS PER DOCUMENT	$225.0K	7
PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X14T(ACCORD-UK AS PER INVOICE	$215.6K	10
PHARMA DRUG&MED:MONTELUKAST 10MG 2X14T(A	$164.8K	4
PHARMA DRUG&MED:MONTELUKAST 10MG 2X14TA	$125.8K	3
PHARMA DRUGS & MEDI MONTELUKAST ACCORD 10 MG AS PER INVOICE	$111.0K	6
PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X14T(ACCORD-UK AS PER INVOICETBS	$101.8K	10
PHARMA DRUGS & MEDI MONTELUKAST APOTEX 1	$79.8K	2
PHARMA DRUGS & MEDI Montelukast Accord 1	$64.9K	10

Intas Pharmaceuticals Limited exports 161 distinct Montelukast formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI MONTELUKAST 10MG 2X1 with 13 shipments worth $372.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Montelukast Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	TORRENT PHARMACEUTICALS LTD	$5.4M	221	14	$24.6K
5	CIPLA LIMITED	$4.6M	92	5	$50.0K
8	INTAS PHARMACEUTICALS LIMITED ★	$3.8M	400	10	$9.4K
10	MSN LABORATORIES PRIVATE LIMITED	$3.2M	295	18	$10.7K
11	TORRENT PHARMACEUTICALS LIMITED	$3.1M	77	13	$39.7K

Intas Pharmaceuticals Limited ranks #8 among 510 Indian Montelukast exporters. Average shipment value of $9.4K compared to the market average of $144.3K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and CIPLA LIMITED.

Which Indian Ports Ship Montelukast Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	537	8.4%
NHAVA SHEVA SEA (INNSA1)	528	8.2%
SAHAR AIR	479	7.4%
SAHAR AIR CARGO ACC (INBOM4)	466	7.2%
DELHI AIR	451	7.0%
JNPT/ NHAVA SHEVA SEA	286	4.4%
JNPT	224	3.5%
MUNDRA SEA	214	3.3%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Montelukast Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 408 individual customs records matching Intas Pharmaceuticals Limited exporting Montelukast, covering 161 formulations to 10 countries via 39 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 138+ countries, 1,324+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Montelukast

Montelukast

Intas Pharmaceuticals Limited — Montelukast Exporter Profile

Intas Pharmaceuticals Limited — Montelukast Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Montelukast?

Who Are the Top Buyers of Montelukast from Intas Pharmaceuticals Limited?

What Is India's Total Montelukast Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Montelukast Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Montelukast Exporters?

What Montelukast Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Montelukast to Key Markets

Australia — TGA

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Montelukast Exporters?

Which Indian Ports Ship Montelukast Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Montelukast Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Montelukast Export Data from Intas Pharmaceuticals Limited

Montelukast Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source